ArticleEClinicalMedicine2026

Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan.

Kenro Hirata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.